Invention Grant
- Patent Title: Fentanyl composition for nasal administration
- Patent Title (中): 芬太尼组合物用于鼻腔给药
-
Application No.: US13188862Application Date: 2011-07-22
-
Publication No.: US08653107B2Publication Date: 2014-02-18
- Inventor: Jesper Grarup , Hanne Wulf Nielsen
- Applicant: Jesper Grarup , Hanne Wulf Nielsen
- Applicant Address: DK Roskilde
- Assignee: Takeda Pharma A/S
- Current Assignee: Takeda Pharma A/S
- Current Assignee Address: DK Roskilde
- Agency: Wenderoth, Lind & Ponack, L.L.P.
- Priority: DK200001154 20000731
- Main IPC: A61K31/445
- IPC: A61K31/445 ; A61K9/12

Abstract:
The treatment of acute pain with a sufficient dosage by intranasal administration of fentanyl results in a time to onset of action comparable to intravenous administration and a significantly faster onset of action than nasal titration of fentanyl. The nasal administration of a sufficient amount of fentanyl to obtain pain relief has lower maximum plasma concentrations comparable to intravenous administration and results in lower rates of adverse events like respiratory depression, nausea and vomiting. Compositions for use in the method are also disclosed.
Public/Granted literature
- US20110281914A1 FENTANYL COMPOSITION FOR NASAL ADMINISTRATION Public/Granted day:2011-11-17
Information query
IPC分类: